The groundbreaking treatment of this peptide represents a major development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and the GIP https://tirzepatide-peptide739220.anchor-blog.com/22416416/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment